NewsWith huge new China mall, Japan’s Aeon puts fun over shoppingNew Wuhan destination offers go-karts, virtual reality and petting zoo. 3 mins read
Amidst changing economic circumstances, China’s e-commerce players are adapting their strategies accordingly to meet evolving consumer demands. InsightsHow are China’s e-commerce titans preparing for this year’s Singles’ Day?4 mins read
Shein and Temu have a history of multiple courtroom battles, contesting a variety of issues. But what is the actual point of their contention? InsightsIs there more to Shein and Temu’s lawsuit than meets the eye?7 mins read
The company’s NFC-based e-receipt solution promises to improve the retail payment experience while appealing to evolving consumer preferences. FeaturesPi-xcels is transforming the retail experience with interactive e-receipts5 mins read
Maps have transcended mere navigation, adapting to diverse digital roles. NextBillion.ai is creating hyperlocal maps to align with this evolution, catering to present and future applications. NewslettersBeyond wayfinding: What you should know about the evolution of maps5 mins read
Shopee risks going back to its old ways as new competitors besiege the Southeast Asian e-commerce market. InsightsShopee braces for e-commerce battle in Southeast Asia as competitors close in6 mins read
That brand is Code Mint, and it has built a user base primarily comprising sophisticated women in China’s first- and second-tier cities. NewsEstee Lauder’s first investment in China is in a clean beauty brand4 mins read
By employing a blend of online and offline strategies, MeToo garners significant sales in Indonesia from selling mouthwash alone. FeaturesThis company makes RMB 130 million a year from selling mouthwash6 mins read
Shein is betting on Forever 21 to open a new frontier in the offline retail space and stave off rising competition. NewsShein steps into offline retail by acquiring one-third of Forever 214 mins read
NewsDeals in brief: FusionAP raises pre-seed funding, SeaX Ventures backs US-based Melazyme, seven China investments, and more
